Basic Science News at Duke School of Medicine

A Duke University School of Medicine team reimagines a sci-fi classic as real-world biotech that can speed up biological research.

An epic collaboration between neuroscientists at Duke and six other institutions has yielded an AI tool that paves the way for new approaches to treating neurological disorders.

New strategy could change how we design drugs—especially the large and polar ones that were once too big to work.

When Hurricane Helene hit Western North Carolina, it left more than flood damage—it fostered mold and fungal growth. Now, a Duke University team is studying how post-disaster fungi could affect health and recovery in a warming world.

A multi-faceted study from Duke University School of Medicine researchers shows for the first time that blocking an under-studied enzyme called PKN2 may be the key to stopping aggressive, treatment-resistant cancers.

A proposed cap on National Institutes of Health funding could cost Duke University millions and stall critical breakthroughs -- like Laurie Sanders's blood test for early Parkinson's disease.

Research by neurobiologists Richard Mooney and John Pearson and postdoctoral associate Jiaxuan Qi sheds light on the brain signals underlying birds' intrinsic desire to learn their songs. The results hold implications for understanding human learning and neurological disorders.

Cigarette and other tobacco smoking are responsible for millions of deaths worldwide each year. Nicotine drives addiction to tobacco, and the brain’s reaction to it is complex.

Annual DARE Awards were presented for groundbreaking research in cancer, neuroscience, cell biology and biochemistry.

Data reveal a new era of lung cancer surgery—less invasive, more precise, and still life-saving.